1. 781TiPPRODIGE 29-UCGI 26(NEOPAN): A randomised trial of chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (PC). (23rd October 2018) Authors: Ducreux, M P; Desgrippes, R; Texier, M; Di Fiore, F; Vanelslander, P; Capitain, O; Guimbaud, R; Forestier, J; El Hajbi, F; Follana, P; Parzy, A; Baba Hamed, N; Rinaldi, Y; Brotelle, T; Pignon, J-P; Jouffroy, C; Dahan, L; Bouche, O Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 94PHPV circulating tumor DNA as predictive biomarker of sustained response to chemotherapy in advanced anal carcinoma. (23rd October 2018) Authors: Bernard-Tessier, A; Jeannot, E; Guenat, D; Michel, M; Proudhon, C; Vincent-Salomon, A; Bièche, I; Pierga, J-Y; Buecher, B; Francois, E; Kim, S; André, T; Jary, M; Vendrely, V; Samalin, E; El Hajbi, F; Baba-Hamed, N; Meurisse, A; Bidard, F-C; Borg, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results. (28th September 2017) Authors: Aparicio, T; Bouché, O; Taieb, J; Maillard, E; Kirscher, S; Etienne, P -L; Faroux, R; Khemissa Akouz, F; El Hajbi, F; Locher, C; Rinaldi, Y; Lecomte, T; Lavau-Denes, S; Baconnier, M; Oden-Gangloff, A; Genet, D; Paillaud, E; Retornaz, F; François, E; Bedenne, L Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗